Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, October 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 48 articles: HTML format

Single Articles

1. LIU Q, Ming Y, Ji C, Fu L, et al
   S100B in brain-gut-liver crosstalk: from glial activation to multiorgan inflammation.
   Front Immunol. 2026;17:1933882.
   PubMed    
   Abstract available
   
   

2. EL-CHAMMAS K, Hagenstein L, Chogle A, Santucci N, et al
   Functional Nausea Is Not Just Nausea: A Multi-Center, Cross-Sectional Study of Children and Young Adults.
   Neurogastroenterol Motil. 2026;38:e70447.
   PubMed    
   Abstract available
   
   

3. MIKHAEL-MOUSSA H, Aupetit A, Guerin O, Desprez C, et al
   When Food Avoidance Meets Compatible Diagnostic Criteria: Avoidant/Restrictive Food Intake Disorder Features in Irritable Bowel Syndrome.
   Neurogastroenterol Motil. 2026;38:e70456.
   PubMed    
   Abstract available
   
   

4. 
   Irritable bowel syndrome.
   Nat Rev Dis Primers. 2026;12:65.
   PubMed    
   
   
   

5. CHANG L, Corsetti M, Chey WD, Ford AC, et al
   Irritable bowel syndrome.
   Nat Rev Dis Primers. 2026;12:64.
   PubMed    
   Abstract available
   
   

6. VENKATARAMAN A, Midavaine E, Ingraham HA
   Sex-specific mechanisms of chronic pain.
   Science. 2026;394:69-74.
   PubMed    
   Abstract available
   
   

7. HUANG Z, Lyu Z, Liu F
   Exploring the psychogastroenterology patterns of functional dyspepsia and irritable bowel syndrome comorbidities based on latent profile analysis.
   Front Pharmacol. 2026;17:1759170.
   PubMed    
   Abstract available
   
   

8. TSAI FP, Chang LC, Tseng PH
   Reply to the comment on "Prevalence and clinical characteristics of irritable bowel syndrome in Taiwan: Rome III versus Rome IV criteria".
   J Formos Med Assoc. 2026 Sep 30:S0929-6646(26)00919.
   PubMed    
   
   
   

9. SOIFER LO, Contreras MV, Man F, Gonzalez-Florez A, et al
   Argentine consensus on the clinical utility of breath tests and small intestinal bacterial overgrowth management in patients with disorders of gut-brain interaction.
   Rev Gastroenterol Mex (Engl Ed). 2026 Sep 30:S2255-534X(26)00072.
   PubMed    
   Abstract available
   
   

10. YU A, Bi Y, Xu X
    Brain-Gut Axis Perspective on Irritable Bowel Syndrome: The Role of Gut Microbiota and Therapeutic Strategies of Traditional Chinese Medicine.
    Am J Chin Med. 2026 Sep 30:1-30. doi: 10.1142/S0192415X26500771.
    PubMed    
    Abstract available
    
    

11. WOELBER JP, Wirth N, Dallmer-Zerbe A, Tennert C, et al
    The oral und systemic health risks of sugar consumption: an umbrella review.
    Clin Oral Investig. 2026;30:490.
    PubMed    
    Abstract available
    
    

12. SUI Y, Li P, Yue X, Chen Y, et al
    Depressive symptoms as a mediator in the association between regular physical activity and irritable bowel syndrome-related symptom severity: a cross-sectional study among college students.
    Front Psychol. 2026;17:1856261.
    PubMed    
    Abstract available
    
    

13. FIROOZI M, Mahdavinezhad A, Shirzad M, Motevaseli E, et al
    Biotechnological Approaches to Probiotics and Postbiotics through the Gut-Brain Axis Modulation.
    Iran Biomed J. 2026;30:193-211.
    PubMed    
    Abstract available
    
    

14. WEI Q, Li L, Du Q, Zhang H, et al
    Bidirectional causal associations between Sjogren syndrome and gastrointestinal disorders: A two-sample Mendelian randomization study.
    Medicine (Baltimore). 2026;105:e50935.
    PubMed    
    Abstract available
    
    

15. RIZZO CE, Anza D, Genovese C, Sciacca D, et al
    Clinical and Public Health Lessons from a Point-Source Polymicrobial Foodborne Outbreak: Implications for Vaccination of Vulnerable Populations.
    Vaccines (Basel). 2026;14:804.
    PubMed    
    Abstract available
    
    

16. OGUTMEN KOC D, Sarbay I, Mercan Baspinar M, Mangal L, et al
    Orlistat-Associated Gastrointestinal, Hepatobiliary, Pancreatic, and Anorectal Safety Signals: A FAERS Disproportionality and Regulatory Label Concordance Study.
    Pharmaceuticals (Basel). 2026;19:1325.
    PubMed    
    Abstract available
    
    

17. TIMURKAAN ES, Timurkaan M, Yildiz S
    Cyberchondria, Psychological Well-Being, Anxiety, and Depression Levels in Female Patients with Irritable Bowel Syndrome.
    Medicina (Kaunas). 2026;62:1621.
    PubMed    
    Abstract available
    
    

18. LUU ATP, Vo TD
    Comparative Effectiveness of Mebeverine and Otilonium Bromide on Health-Related Quality of Life in Patients with Irritable Bowel Syndrome: A Prospective Cohort Study.
    Life (Basel). 2026;16:1390.
    PubMed    
    Abstract available
    
    

19. AKINCI GOKTAS O, Selbuz S
    Primary Headache Disorders in Pediatric Irritable Bowel Syndrome: Characterizing IBS-Associated Migraine Highlights.
    Children (Basel). 2026;13:1230.
    PubMed    
    Abstract available
    
    

20. BOICEA CAMEN AR, Caragea DC, Boldeanu MV, Florescu DN, et al
    Shift Work, Circadian Disruption, and Immune Dysregulation: Molecular Links to Gastrointestinal Diseases and Occupational Health Implications.
    Diagnostics (Basel). 2026;16:3010.
    PubMed    
    Abstract available
    
    

21. GABRIEL EM, Nooriankafshgari F, Garcia-Sierra R, Vallve CS, et al
    Irritable Bowel Syndrome Care in Catalonia: A Qualitative Study with Healthcare Professionals on the Management of Uncertainty and the Possibilities of Technological and Digital Developments.
    Healthcare (Basel). 2026;14:2928.
    PubMed    
    Abstract available
    
    

22. LI L, Zhao C, Wang F, Zhao Q, et al
    Irritable Bowel Syndrome and Incident Hypertension: Epidemiologic and Genetic Insights.
    Biomedicines. 2026;14:2057.
    PubMed    
    Abstract available
    
    

23. DUONG MA, Ramdass PVAK
    ATP-P2X3 Signaling as a Shared Neural Sensitization Pathway in Endometriosis and Irritable Bowel Syndrome: Mechanisms and Therapeutic Implications.
    Biomedicines. 2026;14:1891.
    PubMed    
    Abstract available
    
    

24. YANG W, Liu Y, Wang H, Yang G, et al
    Exercise and Intestinal Barrier Integrity: Molecular Mechanisms and Therapeutic Potential in Gut Health and Disease.
    Biology (Basel). 2026;15:1672.
    PubMed    
    Abstract available
    
    

25. ROUTHIAUX K, Van den Houte K, Balsiger L, Raymenants K, et al
    Avoidant/restrictive food intake across the gastrointestinal tract.
    Clin Gastroenterol Hepatol. 2026 Oct 9:S1542-3565(26)00743.
    PubMed    
    Abstract available
    
    

26. KIM JH, Park SJ, Huh CS, Shin CH, et al
    Lactiplantibacillus Plantarum CKDB008 and Lacticaseibacillus Rhamnosus LDTM7511 Attenuate Visceral Hypersensitivity and Suppress Serum IgE in an Acetic Acid-Induced IBS-Like Rat Model.
    Probiotics Antimicrob Proteins. 2026 Oct 9. doi: 10.1007/s12602-026-11238.
    PubMed    
    Abstract available
    
    

27. PAN L, Ran P, Jiang F, Wang Y, et al
    Role of Bile Acid Receptors in Non-Infectious Diarrhea: A Narrative Review.
    Med Sci Monit. 2026;32:e952723.
    PubMed    
    Abstract available
    
    

28. LI W, Zhang Z, Lu C, Xu Y, et al
    Frailty and risk of common chronic diseases among cancer survivors: a prospective cohort study.
    J Cancer Surviv. 2026 Oct 9. doi: 10.1007/s11764-026-02118.
    PubMed    
    Abstract available
    
    

29. HOD K, Marasco G, Colecchia L, Sperber AD, et al
    Life-course hygiene exposures and disorders of gut-brain interaction: a multinational cross-sectional study.
    Intern Emerg Med. 2026 Oct 8. doi: 10.1007/s11739-026-04546.
    PubMed    
    Abstract available
    
    

30. RUBING W, Jinying Z, Lingzu K, Xu F, et al
    Visualization analysis of research hotspots and trends in traditional Chinese medicine external therapies for irritable bowel syndrome.
    Front Med (Lausanne). 2026;13:1954763.
    PubMed    
    Abstract available
    
    

31. MIN JH, Jo YW, Her Y, Kwon JW, et al
    Gut-Skin Axis Revisited: A Nationwide Cohort Study on the Bi-directional Relationship Between Rosacea and Irritable Bowel Syndrome.
    Ann Dermatol. 2026;38:388-396.
    PubMed    
    Abstract available
    
    

32. TALEBI SS, Ahmadimoghaddam D, Mirjalili M, Keshavarzi A, et al
    Agomelatine improves symptom severity and quality of life in diarrhea-predominant irritable bowel syndrome: insights from a randomized controlled clinical trial.
    Naunyn Schmiedebergs Arch Pharmacol. 2026 Oct 8. doi: 10.1007/s00210-026-05975.
    PubMed    
    Abstract available
    
    

33. STALLER K, Goodoory VC, Khasawneh M, Black CJ, et al
    Validation of Rome V for irritable bowel syndrome - Authors' reply.
    Lancet Gastroenterol Hepatol. 2026;11:955-956.
    PubMed    
    
    
    

34. SIMREN M, Aziz I, Tack J
    Validation of Rome V for irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2026;11:954-955.
    PubMed    
    
    
    

35. NG DYL, Biesiekierski J, Hebbard G, Talley NJ, et al
    Validation of Rome V for irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2026;11:953-954.
    PubMed    
    
    
    

36. HASANUZZAMAN M, Bang CS, Lee JJ, Gong EJ, et al
    Fecal Microbiota Transplantation Beyond Clostridioides difficile Infection: Expanding Indications, Mechanisms, and Future Directions.
    J Korean Med Sci. 2026;41:e335.
    PubMed    
    Abstract available
    
    

37. GUADANO-PROCESI I, Garcia Ramos A, Gentekaki E, Tsaousis AD, et al
    Exploring Blastocystis: hidden complexity in a common intestinal microbe.
    J Med Microbiol. 2026;75:002198.
    PubMed    
    Abstract available
    
    

38. REZAZADEGAN M, Saneei P, Soheilipour M, Rezazadegan N, et al
    Co-supplementation of zinc and probiotic on oxidative stress markers and sleep quality index in irritable bowel syndrome patients: a double-blind randomized controlled trial.
    Eur J Nutr. 2026;65:273.
    PubMed    
    Abstract available
    
    

39. MONTGOMERY S, Saraga A, Rothschild NDV, Soliman MA, et al
    Irritable bowel syndrome-like symptoms are associated with increased healthcare utilization in patients with inflammatory bowel disease.
    Front Gastroenterol (Lausanne). 2026;5:1924176.
    PubMed    
    Abstract available
    
    

40. TIAN L, Bai Y, Wang S, Wang C, et al
    Codonopsis pilosula inulin-type fructan CPA ameliorates diarrhea-predominant irritable bowel syndrome via regulation of ER stress-induced autophagy and modulation of gut microbiota.
    Front Pharmacol. 2026;17:1715972.
    PubMed    
    Abstract available
    
    

41. BOSMAN M, Vork L, Van Den Houte M, van Oudenhove L, et al
    Real-time abdominal pain - daily life trigger associations in IBS: a multicenter Experience Sampling Method Study.
    Clin Gastroenterol Hepatol. 2026 Oct 6:S1542-3565(26)00747.
    PubMed    
    Abstract available
    
    

42. LIMAYE S, Bhide P, Kale A, Bokey N, et al
    SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India.
    J Microbiol Biotechnol. 2026;36:e2605029.
    PubMed    
    Abstract available
    
    

43. ATEF M, Abdalaziz RA, Badry A, Darweesh H, et al
    The diagnostic utility of abdominal and bowel ultrasound in detecting gastrointestinal and hepatic manifestations of rheumatoid arthritis.
    Arab J Gastroenterol. 2026 Oct 5:S1687-1979(26)00116.
    PubMed    
    Abstract available
    
    

44. VAN VORSTENBOSCH R, Esenkova EE, Jonkers DMAE, Elizalde Vilalta M, et al
    Investigating the presence of microbiota-based phenotypes in Irritable Bowel Syndrome.
    J Breath Res. 2026 Oct 5. doi: 10.1088/1752-7163.
    PubMed    
    Abstract available
    
    

45. STALLER K, Clukey J, Madva EN, Healy BC, et al
    CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose Nortriptyline for Irritable Bowel Syndrome With Diarrhea.
    Gastro Hep Adv. 2026;5:101111.
    PubMed    
    
    
    

46. WANG PF
    Letter: Timing Matters-Interpreting Colonic Gas Reduction With Gel-Forming Fibres.
    Aliment Pharmacol Ther. 2026 Sep 27. doi: 10.1111/apt.71023.
    PubMed    
    
    
    

47. PERERA P, Wickramasinghe D, Wannakuwatta R, Wickramasinghe DP, et al
    Bowel habits and functional bowel disorders in Sri Lankan adults: A cross-sectional study.
    Indian J Gastroenterol. 2026 Sep 25. doi: 10.1007/s12664-026-02049.
    PubMed    
    Abstract available
    
    

48. RAMISCH M, Benz-Sahnoun S, Guenther V, Korn A, et al
    Personalized psychotherapy in irritable bowel syndrome: results from a pilot randomized controlled trial (PIONEER-IBS).
    J Psychosom Res. 2026;211:113003.
    PubMed    
    Abstract available